Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

Keyphrases

• Myocardium 100%
• Cardiac Tissue 100%
• Vector Genomes 100%
• Recombinant Adeno-associated Virus Serotype 9 100%
• Gene Transfer 66%
• Recombinant Adeno-associated Virus (rAAV) 66%
• Biodistribution 66%
• LacZ 66%
• Intravenous Delivery 66%
• Nonhuman Primate 33%
• Vasculature 33%
• Virus 33%
• Capsid 33%
• Skeletal muscle 33%
• Mouse Model 33%
• Pompe Disease 33%
• High Dose 33%
• Heart Disease 33%
• Gene Delivery 33%
• Virus Serotype 33%
• Expression Data 33%
• Adult Mice 33%
• Genetic Defects 33%
• Genome Copy number 33%
• Extracardiac 33%
• AAV Serotypes 33%
• Physiological Disease 33%
• Neonatal Injection 33%
• AAV9 33%
• ECG Tracing 33%
• Transfer Approach 33%
• Neonatal Mice 33%

Biochemistry, Genetics and Molecular Biology

• in Vivo Gene Transfer 100%
• Adeno Associated Virus 100%
• Serotype 100%
• Biodistribution 66%
• Genetics 33%
• Mouse Model 33%
• Vascularization 33%
• Capsid 33%
• Skeletal Muscle 33%
• Gene Targeting 33%
• Electrocardiogram 33%
• Drug Megadose 33%